Riboflavin supplementation to patients with multiple sclerosis does not improve disability status nor is riboflavin supplementation correlated to homocysteine

International Journal for Vitamin and Nutrition Research

Volumn 83, Issue 5, 2013, Pages 281-290

  Naghashpour, Mahshid ^a   Majdinasab, Nastaran ^a   Shakerinejad, Ghodratollah ^b   Kouchak, Maryam ^a   Haghighizadeh, Mohammad Hosein ^a   Jarvandi, Farzaneh ^b   Hajinajaf, Saideh ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Computer Engineering   (Iran)

Author keywords

EDSS; Homocysteine; Multiple sclerosis; Riboflavin

Indexed keywords

HOMOCYSTEINE; PLACEBO; RIBOFLAVIN; GLUTATHIONE REDUCTASE; VITAMIN B COMPLEX;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DOUBLE BLIND PROCEDURE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; MULTIPLE SCLEROSIS; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RIBOFLAVIN DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; DIET SUPPLEMENTATION; DRUG EFFECTS; ERYTHROCYTE;

ADULT; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ERYTHROCYTES; FEMALE; GLUTATHIONE REDUCTASE; HOMOCYSTEINE; HUMANS; MALE; MULTIPLE SCLEROSIS; RIBOFLAVIN; VITAMIN B COMPLEX;

EID: 84910616180     PISSN: 03009831     EISSN: 16642821     Source Type: Journal    
DOI: 10.1024/0300-9831/a000170     Document Type: Article

References (31)

1. Lublin, F.D. and Miller, A.E. (2008) Multiple Sclerosis and other Inflammatory Demyelinating Disease of the Central Nervous System. In: Neurology in Clinical Practice. (Bradley, W.G., ed.) vol. 5, pp. 1583-1613, Butterworth Heinemann Elsevier, Philadelphia.
2. Ghaem, H., Haghighi, A.B., Jafari, P. and Nikseresht, A.R. (2007) Validity and reliability of the Persianversion of the multiple sclerosis quality of lifequestionnaire. Neural. India. 55, 369-375.
3. Twork, S., Wiesmeth, S., Spindler, M., Wirtz, M., Schipper, S., Pöhlau, D., Klewer, J. and Kugler, J. (2010) Disability status and quality of life in multiplesclerosis: non-linearity of the Expanded Disability Status Scale (EDSS). Health Qual. Life. Outcomes. 8, 1-6.
4. Hadgkiss, E.J., Jelinek, G.A., Weiland, T.J., Rumbold, G., Mackinlay, C.A., Gutbrod, S. and Gawler, I. (2013) Health-related quality of life outcomes at 1 and 5 years after a residential retreat promotinglifestyle modification for people with multiplesclerosis. Neurol. Sci. 34, 187-195.
5. Gallager, M.L. (2008) The Nutrients and Their Metabolism. In: Krausés Food & Nutrition Therapy (Mahan, L.K. and Escott-Stump, S., ed.) vol. 12, pp. 74-78, 84-86, Saunders, Philadelphia.
6. Ogunleye, A.J. and Odutuga, A.A. (1989) The effect ofriboflavin deficiency on cerebrum and cerebellum ofdeveloping rat brain. J. Nutr. Sci. Vitaminol. 35,193-7.
7. Ghadirian, P., Jain, M., Ducic, S., Shatenstein, B. and Morisset, R. (1998) Nutritional factors in the etiologyof multiple sclerosis: a case-control study in Montreal, Canada. Int. J. Epidemiol. 27, 845-852.
8. Cai, Z., Finnie, J.W., Blumbergs, P.C., Manavis, J., Ghabriel, M.N. and Thompson, P.D. (2006) Earlyparanodal myelin swellings (tomacula) in an avianriboflavin deficiency model of demyelinatingneuropathy. Exp. Neurol. 198, 65-71.
9. Cai, Z., Finnie, J.W. and Blumbergs, P.C. (2006) Avian riboflavin deficiency: an acquired tomaculousneuropathy. Vet. Pathol. 43,780-781.
10. Triantafyllou, N., Evangelopoulos, M.E., Kimiskidis, V.K., Kararizou, E., Boufidou, F., Fountoulakis, K.N., Siamouli, M., Nikolaou, C., Sfagos, C., Vlaikidis, N. and Vassilopoulos, D. (2008) Increased plasmahomocysteine levels in patients with multiple sclerosisand depression. Ann. Gen. Psychiatry., 7, 1-5.
11. Heese, P., Linnebank, M., Semmler, A., Muschler, M. A.N., Heberlein, A., Frieling, H., Stoffel-Wagner, B., Kornhuber, J., Banger, M., Bleich, S. and Hillemacher, T. (2012) Alterations of homocysteine serum levelsduring alcohol withdrawal are influenced by folateand riboflavin: results from the German investigationon neurobiology in alcoholism (GINA). Alcohol and Alcoholism 47, 497-500.
12. Ganji, V. and Kafai, M.R. (2004) Frequentconsumption of milk, yogurt, cold breakfast cereals, peppers, and cruciferous vegetables and intakes ofdietary folate and riboflavin but not vitamins B-12 and B-6 are inversely associated with serum totalhomocysteine concentrations in the US population. Am. J. Clin. Nutr. 80, 1500-7.
13. Araki, R., Maruyama, C., Igarashi, S., Yoshida, M. Maruyama, T. Satoh, T. Yoshida, M. and Umegaki, K. (2006) Effects of short-term folic acid and/orriboflavin supplementation on serum folate andplasma total homocysteine concentrations in young Japanese male subjects. Eur. J. Clin. Nutr. 60,573-9.
14. Vujkovic, M., Steegers, E.A., van Meurs, J., Yazdanpanah, N., van Rooij, I.A., Uitterlinden, A.G. and Steegers-Theunissen, R.P. (2010) The maternalhomocysteine pathway is influenced by riboflavinintake and MTHFR polymorphisms without affectingthe risk of orofacial clefts in the offspring. Eur. J. Clin. Nutr. 64, 266-73.
15. McDonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D., McFarland, H.F., Paty, D.W., Polman, C.H., Reingold, S.C., Sandberg-Wollheim, M., Sibley, W., Thompson, A., van denNoort, S., Weinshenker, B.Y. and Wolinsky, J.S. (2001) Recommended diagnostic criteria for multiplesclerosis: Guidelines from the international panel onthe diagnosis of multiple sclerosis. Ann. Neurol. 50, 121-27.
16. Bisaga, G.N., Odinak, M.M., Bo ko, A.N., Mel'nik, I.B. and Popova, N.F. (2011) Possibilities of treatmentof multiple sclerosis exacerbations withoutcorticosteroids: a role of metabolic and antioxidanttherapy. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova. 111, 44-8.
17. Kurn, S. and Shook, S. Integrated medicine forneurologic disorders: herbs and nutrients for Alzheimer's disease, Parkinson's disease, multiplesclerosis, stroke, migraine, and seizures. In: Multiple Sclerosis. p. 38, Health Press NA, Inc. Albuquerque, New Mexico.
18. Macdonald, J.L. Roberts, D.F. Shaw, D.A. and Saunders, M. (1976) Blood groups and other polymorphisms inmultiple sclerosis. Journal of Medical Genetics 13, 30-33.
19. Goldberg, D.M. and Spooner, R.J. (1983) Methodsof enzymatic analysis. pp. 258-265, Verlog Chemie, Deerfield Beach.
20. Naghashpour, M., Amani, R., Nematpour, S. and Haghighizadeh, M.H. (2011) Riboflavin status and itsassociation with serum hs-CRP levels among clinicalnurses with depression. J. Am. Coll. Nutr. 30, 340-7.
21. Sauberlich, H. (1999) Laboratory Tests for the Assessment of Nutritional Status. Second ed., pp. 60-64. CRC Press, Florida.
22. Frantzen, F., Faaren, A.l., Alfheim, I. and Nordhei, A.K. (1998) Enzyme conversion immunoassay fordetermining total homocysteine in plasma or serum. Clin. Chem. 44, 311-316.
23. Campolo, J., De Chiara, B., Caruso, R., De Maria, R., Sedda, V., Dellanoce, C., Parolini, M., Cighetti, G., Penco, S., Baudo, F. and Parodi, O. (2006) Methioninechallenge paradoxically induces a greater activationof the antioxidant defence in subjects with hyper-vs. normohomocysteinemia. Free Radic. Res. 40, 929-35.
24. Healy, B.C., Engler, D., Glanz, B., Musallam, A. and Chitnis, T. (2013) Assessment of definitions ofsustained disease progression in relapsing-remittingmultiple sclerosis. Mult. Scler. Int. 2013, 1-9.
25. Riccio, P., Rossano, R. and Liuzzi, G. (2010) May dietand dietary supplements improve the wellness ofmultiple sclerosis patients? A molecular approach. Autoimmune Dis. 2010, 1-12.
26. Mastronardi, F.G., Min, W., Wang, H., Winer, S., Dosch, M., Boggs, J.M. and Moscarello, M.A. (2004) Attenuation of experimental autoimmuneencephalomyelitis and nonimmune demyelination byIFN-β plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance. J. Immuno. 172, 6418-6426.
27. Zoccolella, S., Tortorella, C., Iaffaldano, P., Direnzo, V., D'Onghia, M., Paolicelli, D., Livrea, P. and Trojano, M. (2012) Elevated plasma homocysteine levels inpatients with multiple sclerosis are associated withthe male gender. J. Neurol. 259, 2105-10.
28. Bul'on, V.V., Kuznetsova, N.N., Selina, E.N., Kovalenko, A.L., Alekseeva, L.E. and Sapronov, N.S. (2005) The neuroprotective effect of cytoflavin duringcompression injury of the spinal cord. Bull. Exp. Biol. Med. 139, 394-6.
29. Zhu, Y., Liu, H.N., Zhang, C.D. and Liang, H.Y. (2009) Meta-analysis on relationship betweenhyperhomocysteinemia and multiple sclerosis. 89, 3055-7.
30. Sahin, S., Aksungar, F.B., Topkaya, A.E., Yildiz, Z., Boru, U.T., Ayalp, S. and Karsidag, S. (2007) Increasedplasma homocysteine levels in multiple sclerosis. Mult. Scler. 13, 945-6.
31. Tewarie, P., Teunissen, C.E., Dijkstra, C.D., DAMH, Vogt, M., Balk, L., Vrenken, H., Polman, C.H. and Killestein, J. (2012) Cerebro-spinal fluid anti-wholemyelin antibodies are not correlated to magneticresonance imaging activity in multiple sclerosis. J. Neuroimmunol. 251, 103-6.